BOLD - Company ID 0001782303
Boundless Bio, Inc. trades as BOLD. This page tracks Boundless Bio, Inc. through 127 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-05-08 |
| Annual report to shareholders | ARS | 2026-04-28 |
| Proxy materials | DEFA14A | 2026-04-28 |
| Proxy statement | DEF 14A | 2026-04-28 |
| Major company event | 8-K | 2026-04-13 |
| Annual report | 10-K | 2026-03-09 |
| Major company event | 8-K | 2026-03-09 |
The largest companies sharing Boundless Bio, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Boundless Bio, Inc. reported a net loss of $58.20M.